These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Salivary hypofunction in patients with familial amyloidotic polyneuropathy. Johansson I; Ryberg M; Steen L; Wigren L Oral Surg Oral Med Oral Pathol; 1992 Dec; 74(6):742-8. PubMed ID: 1488230 [TBL] [Abstract][Full Text] [Related]
26. [Chronic polyneuropathy--evaluation and diagnosis]. Mygland A Tidsskr Nor Laegeforen; 2007 Feb; 127(3):291-5. PubMed ID: 17279107 [TBL] [Abstract][Full Text] [Related]
27. Use of SEPs to localize degeneration in a rare polyneuropathy: studies on polyneuropathy associated with pigmentation, hypertrichosis, edema, and plasma cell dyscrasia. Shibasaki H; Ohnishi A; Kuroiwa Y Ann Neurol; 1982 Oct; 12(4):355-60. PubMed ID: 7149661 [TBL] [Abstract][Full Text] [Related]
30. Drug therapy for chronic idiopathic axonal polyneuropathy. Vrancken AF; van Schaik IN; Hughes RA; Notermans NC Cochrane Database Syst Rev; 2004; (2):CD003456. PubMed ID: 15106203 [TBL] [Abstract][Full Text] [Related]
31. Aspects of chronic polyneuropathy associated with myeloma. Morley JB; Schwieger AC Proc Aust Assoc Neurol; 1968; 5(2):403-4. PubMed ID: 5707163 [No Abstract] [Full Text] [Related]
32. Prevalence of polyneuropathy in the general middle-aged and elderly population. Hanewinckel R; Drenthen J; van Oijen M; Hofman A; van Doorn PA; Ikram MA Neurology; 2016 Nov; 87(18):1892-1898. PubMed ID: 27683845 [TBL] [Abstract][Full Text] [Related]